Endo-oncology Clinical Research:
We are currently engaging in a number research projects to understand the incidence, clinical presentation and mechanisms behind endocrine immune-related adverse events related to treatment with novel cancer immunotherapies, in particular immune checkpoint inhibitors.
These studies will help us further comprehend which individuals are at risk for such side effects, as well as assist with the development of appropriate screening measures and treatment plans for our patients. The results of our work have been presented in national and international endocrine meetings and were recently published. This program was awarded a research grant from the Israel Cancer Association.